The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Neri, Marcella ^a   Valli, Emanuele ^b   Alfano, Giovanna ^c   Bovolenta, Matteo ^a   Spitali, Pietro ^a   Rapezzi, Claudio ^d   Muntoni, Francesco ^e   Banfi, Sandro ^c   Perini, Giovanni ^b   Gualandi, Francesca ^a   Ferlini, Alessandra ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DYSTROPHIN; GUANOSINE; ISOPROTEIN;

5' X LINKED DILATED CARDIOMYOPATHY; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SKELETAL MUSCLE; DNA METHYLATION; GENETICS; METABOLISM; X CHROMOSOME LINKED DISORDER;

CARDIOMYOPATHY, DILATED; DNA METHYLATION; DYSTROPHIN; GENETIC DISEASES, X-LINKED; HEART VENTRICLES; HUMANS; IN SITU HYBRIDIZATION; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84858975848     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-20     Document Type: Article

References (34)

1. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003, 2(12):731-740. 10.1016/S1474-4422(03)00585-4, 14636778.
2. Boyce FM, Beggs AH, Feener C, Kunkel LM. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA 1991, 88(4):1276-1280. 10.1073/pnas.88.4.1276, 51000, 1996328.
3. Bies RD, Friedman D, Roberts R, Perryman MB, Caskey CT. Expression and localization of dystrophin in human cardiac Purkinje fibers. Circulation 1992, 86(1):147-153.
4. Muntoni F, Wilson L, Marrosu G, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 1995, 96(2):693-699. 10.1172/JCI118112, 185251, 7635962.
5. Holder E, Maeda M, Bies RD. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 1996, 97(2):232-239. 10.1007/BF02265272, 8566960.
6. Torelli S, Ferlini A, Obici L, Sewry C, Muntoni F. Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle. Neuromuscul Disord 1999, 9(8):541-551. 10.1016/S0960-8966(99)00048-6, 10619711.
7. Muntoni F, Melis MA, Ganau A, Dubowitz V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet 1995, 56(1):151-157. 1801315, 7825571.
8. Ferlini A, Sewry C, Melis MA, Mateddu A, Muntoni F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 1999, 9(5):339-346. 10.1016/S0960-8966(99)00015-2, 10407857.
9. Cohen N, Muntoni F. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 2004, 90(8):835-841. 10.1136/hrt.2003.023390, 1768363, 15253946.
10. Neri M, Torelli S, Brown S, Ugo I, Sabatelli P, Merlini L, Spitali P, Rimessi P, Gualandi F, Sewry C, et al. Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. Neuromuscul Disord 2007, 17(11-12):913-918. 10.1016/j.nmd.2007.07.005, 17826093.
11. Kimura S, Ikezawa M, Ozasa S, Ito K, Ueno H, Yoshioka K, Ijiri S, Nomura K, Nakamura K, Matuskura M, et al. Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy. J Child Neurol 2007, 22(7):901-906. 10.1177/0883073807304705, 17715288.
12. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 1996, 5(1):73-79. 10.1093/hmg/5.1.73, 8789442.
13. Yoshida K, Nakamura A, Yazaki M, Ikeda S, Takeda S. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum Mol Genet 1998, 7(7):1129-1132. 10.1093/hmg/7.7.1129, 9618170.
14. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993, 329(13):921-925. 10.1056/NEJM199309233291304, 8361506.
15. Bastianutto C, Bestard JA, Lahnakoski K, Broere D, De Visser M, Zaccolo M, Pozzan T, Ferlini A, Muntoni F, Patarnello T, et al. Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet 2001, 10(23):2627-2635. 10.1093/hmg/10.23.2627, 11726549.
16. Nakamura A, Ikeda S, Yazaki M, Yoshida K, Kobayashi O, Yanagisawa N, Takeda S. Up-regulation of the brain and Purkinje-cell forms of dystrophin transcripts, in Becker muscular dystrophy. Am J Hum Genet 1997, 60(6):1555-1558. 10.1016/S0002-9297(07)64253-0, 1716124, 9199582.
17. De Repentigny Y, Marshall P, Worton RG, Kothary R. The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice. Hum Mol Genet 2004, 13(22):2853-2862. 10.1093/hmg/ddh305, 15385445.
18. Nguyen AT, Xiao B, Neppl RL, Kallin EM, Li J, Chen T, Wang DZ, Xiao X, Zhang Y. DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev 2011, 25(3):263-274. 10.1101/gad.2018511, 3034901, 21289070.
19. Rapezzi C, Leone O, Biagini E, Coccolo F. Echocardiographic clues to diagnosis of dystrophin related dilated cardiomyopathy. Heart 2007, 93(1):10. 10.1136/hrt.2006.087643, 1861327, 17170335.
20. Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Pfeufer A, et al. Functional profiling of human atrial and ventricular gene expression. Pflugers Arch 2005, 450(4):201-208. 10.1007/s00424-005-1404-8, 15877233.
21. Ricotti V, Roberts RG, Muntoni F. Dystrophin and the brain. Dev Med Child Neurol 2011, 53(1):12. 10.1111/j.1469-8749.2010.03836.x, 21171237.
22. Mehler MF. Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev 2000, 32(1):277-307.
23. Rando TA. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001, 24(12):1575-1594. 10.1002/mus.1192, 11745966.
24. Wang GF, Nikovits W, Schleinitz M, Stockdale FE. Atrial chamber-specific expression of the slow myosin heavy chain 3 gene in the embryonic heart. J Biol Chem 1996, 271(33):19836-19845. 10.1074/jbc.271.33.19836, 8702693.
25. Zammit PS, Kelly RG, Franco D, Brown N, Moorman AF, Buckingham ME. Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart. Dev Dyn 2000, 217(1):75-85. 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L, 10679931.
26. Wang GF, Nikovits W, Bao ZZ, Stockdale FE. Irx4 forms an inhibitory complex with the vitamin D and retinoic X receptors to regulate cardiac chamber-specific slow MyHC3 expression. J Biol Chem 2001, 276(31):28835-28841. 10.1074/jbc.M103716200, 11382777.
27. Small EM, Krieg PA. Expression of atrial natriuretic factor (ANF) during Xenopus cardiac development. Dev Genes Evol 2000, 210(12):638-640. 10.1007/s004270000104, 11151301.
28. Makover A, Zuk D, Breakstone J, Yaffe D, Nudel U. Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure. Neuromuscul Disord 1991, 1:39-45. 10.1016/0960-8966(91)90041-P, 1822776.
29. Patrinos GP, de Krom M, de Boer E, Langeveld A, Imam AM, Strouboulis J, de Laat W, Grosveld FG. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev 2004, 18(12):1495-1509. 10.1101/gad.289704, 423198, 15198986.
30. Fang X, Xiang P, Yin W, Stamatoyannopoulos G, Li Q. Cooperativeness of the higher chromatin structure of the beta-globin locus revealed by the deletion mutations of DNase I hypersensitive site 3 of the LCR. J Mol Biol 2007, 365(1):31-37. 10.1016/j.jmb.2006.09.072, 2826273, 17056066.
31. Tewari R, Gillemans N, Harper A, Wijgerde M, Zafarana G, Drabek D, Grosveld F, Philipsen S. The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene. Development 1996, 122(12):3991-3999.
32. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 2009, 23:3335-3346. 10.1096/fj.08-128579, 19528256.
33. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, Nicoletti C, Santini T, Sthandier O, Barberi L, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 2010, 12:341-351. 10.1016/j.cmet.2010.07.008, 20727829.
34. Conte I, Lestingi M, den Hollander A, Miano MG, Alfano G, Circolo D, Pugliese M, Testa F, Simonelli F, Rinaldi E, et al. Characterization of MPP4, a gene highly expressed in photoreceptor cells, and mutation analysis in retinitis pigmentosa. Gene 2002, 297(1-2):33-38. 10.1016/S0378-1119(02)00872-7, 12384283.